Your browser doesn't support javascript.
loading
A Randomized, Multicenter, Double-blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of a Quadruple Combination of Amlodipine, Losartan, Rosuvastatin, and Ezetimibe in Patients with Concomitant Essential Hypertension and Dyslipidemia.
Kim, Min Chul; Ahn, Youngkeun; Kim, Moo Hyun; Kim, Seok-Yeon; Hong, Taek Jong; Rhee, Moo-Yong; Kim, Sang-Hyun; Hong, Soon-Jun; Kim, Hyungseop; Kim, Weon; Chae, In Ho; Kang, Duk-Hyun; Kim, Byeong-Keuk; Kim, Hyo-Soo.
Afiliación
  • Kim MC; Division of Cardiology, Department of Internal Medicine, Chonnam National University Hospital, Chonnam National University Medical School, Gwangju, Republic of Korea.
  • Ahn Y; Division of Cardiology, Department of Internal Medicine, Chonnam National University Hospital, Chonnam National University Medical School, Gwangju, Republic of Korea.
  • Kim MH; Department of Cardiology, Dong-A University Medical School, Pusan, Republic of Korea.
  • Kim SY; Department of Cardiology, Seoul Medical Center, Seoul, Republic of Korea.
  • Hong TJ; Division of Cardiology, Department of Internal Medicine, Pusan National University Medical School, Pusan, Republic of Korea.
  • Rhee MY; Cardiovascular Center, Dongguk University Ilsan Hospital, Goyang, Republic of Korea.
  • Kim SH; Division of Cardiology, Department of Internal Medicine, SMG-SNU Seoul Boramae Hospital, Seoul National University Medical School, Seoul, Republic of Korea.
  • Hong SJ; Department of Cardiology, Cardiovascular Center, Korea University College of Medicine, Seoul, Republic of Korea.
  • Kim H; Keimyung University Dongsan Medical Center, Daegu, Republic of Korea.
  • Kim W; Division of Cardiovascular, Department of Internal Medicine, Kyung Hee University Hospital, Kyung Hee University Medical School, Seoul, Republic of Korea.
  • Chae IH; Cardiovascular Center, Seoul National University Bundang Hospital, Seoul National University Hospital, Seongnam, Republic of Korea.
  • Kang DH; Division of Cardiology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.
  • Kim BK; Division of Cardiology, Department of Internal Medicine, Severance Cardiovascular Hospital, Yonsei University College of Medicine, Seoul, Republic of Korea.
  • Kim HS; Department of Internal Medicine, Cardiovascular Center, Seoul National University Hospital, Seoul National University Medical School, 101, Daehak-ro, Jongro-gu, Seoul, 03080, Republic of Korea. hyosoo@snu.ac.kr.
Am J Cardiovasc Drugs ; 23(4): 441-454, 2023 Jul.
Article en En | MEDLINE | ID: mdl-37395974
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Contexto en salud: 1_ASSA2030 / 2_ODS3 Problema de salud: 1_doencas_nao_transmissiveis / 2_muertes_prematuras_enfermedades_notrasmisibles Asunto principal: Dislipidemias / Hipertensión Tipo de estudio: Clinical_trials Límite: Humans Idioma: En Revista: Am J Cardiovasc Drugs Asunto de la revista: ANGIOLOGIA / CARDIOLOGIA / TERAPIA POR MEDICAMENTOS Año: 2023 Tipo del documento: Article
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Contexto en salud: 1_ASSA2030 / 2_ODS3 Problema de salud: 1_doencas_nao_transmissiveis / 2_muertes_prematuras_enfermedades_notrasmisibles Asunto principal: Dislipidemias / Hipertensión Tipo de estudio: Clinical_trials Límite: Humans Idioma: En Revista: Am J Cardiovasc Drugs Asunto de la revista: ANGIOLOGIA / CARDIOLOGIA / TERAPIA POR MEDICAMENTOS Año: 2023 Tipo del documento: Article